Editorial

Pharmaceuticals, pharmacists and profits: a health policy perspective

Philip Clarke
  • 4 July 2014
  • 4 min read
Editorial

Differences in Australian and New Zealand medicines funding policies

Zaheer-Ud-Din Babar, Agnes Vitry
  • 4 July 2014
  • 4 min read
Experimental and clinical pharmacology

Janus kinase inhibitors: Mechanisms of action

Paul Kubler
  • 1 October 2014
  • 5 min read
Feature

Medicines Safety Update

  • 1 October 2014
  • 7 min read
Experimental and clinical pharmacology

Janus kinase inhibitors in rheumatoid arthritis: Clinical applications

Jennifer Walker, Malcolm Smith
  • 1 October 2014
  • 4 min read
Experimental and clinical pharmacology

Janus kinase inhibitors in myeloproliferative neoplasms: Clinical applications

Ali Bazargan, Constantine Tam
  • 1 October 2014
  • 3 min read
Letters to the Editor

Intravenous paracetamol in paediatrics: cause for concern

  • 1 September 2014
  • 3 min read
Letters to the Editor

Glycated haemoglobin

Ashraf Saleh, Michael d’Emden
  • 1 September 2014
  • 2 min read
Letters to the Editor

The ‘polypill’

  • 1 October 2014
  • 1 min read
Dental notes

Topical corticosteroids and oral mucosa

Christopher Daly
  • 1 October 2014
  • 2 min read
Book review

Stockley’s Drug Interactions, Pocket Companion

Helen Trenerry
  • 1 October 2014
  • 1 min read
NEW DRUGS

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe